Log In
Print
BCIQ
Print
Print this Print this
 

Lexiscan, Rapiscan, regadenoson (CVT-3146)

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionShort-acting adenosine A2A receptor (ADORA2A) agonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor agonist
Latest Stage of DevelopmentMarketed
IndicationCardiovascular, Diagnostic
Partner

Astellas Pharma Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today